BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 1996987)

  • 1. Hepatic glucocorticoid receptor behaves differently when its hormone binding site is occupied by agonist (triamcinolone acetonide) or antagonist (RU486) steroid ligands.
    Moudgil VK; Gunda M
    Biochem Biophys Res Commun; 1991 Feb; 174(3):1239-47. PubMed ID: 1996987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of RU486 and deacylcortivazol to the glucocorticoid receptor is insensitive to sulfhydryl-modifying agents.
    Burollaud T; Danzé PM; Tbarka N; Formstecher P; Dautrevaux M
    J Steroid Biochem Mol Biol; 1993 Mar; 44(3):217-25. PubMed ID: 8461255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of rat liver glucocorticoid receptor with a newly synthesized antisteroid ZK98299.
    Zakula Z; Moudgil VK
    Biochim Biophys Acta; 1991 Apr; 1092(2):188-95. PubMed ID: 2018785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mammalian progesterone receptor shows differential sensitivity to sulfhydryl group modifying agents when bound to agonist and antagonist ligands.
    Moudgil VK; Anter MJ; Hurd C
    J Biol Chem; 1989 Feb; 264(4):2203-11. PubMed ID: 2914901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The steroid antagonist RU486 exerts different effects on the glucocorticoid and progesterone receptors.
    Beck CA; Estes PA; Bona BJ; Muro-Cacho CA; Nordeen SK; Edwards DP
    Endocrinology; 1993 Aug; 133(2):728-40. PubMed ID: 8344212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of rat liver glucocorticoid receptor bound to the antiglucocorticoid RU38486.
    Agarwal MK; Lombardo G; Eliezer N; Moudgil VK
    Biochem Biophys Res Commun; 1985 Dec; 133(2):745-52. PubMed ID: 4084295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in the "zinc fingers" or in the N-terminal region of the DNA binding domain of the human glucocorticosteroid receptor facilitate its salt-induced transformation, but do not modify hormone binding.
    Segard-Maurel I; Jibard N; Schweizer-Groyer G; Cadepond F; Baulieu EE
    J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):727-32. PubMed ID: 1562546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physical characterization of the activated and non-activated forms of the glucocorticoid-receptor complex bound to the steroid antagonist [3H]RU 486.
    Sablonniere B; Danze PM; Formstecher P; Lefebvre P; Dautrevaux M
    J Steroid Biochem; 1986 Nov; 25(5A):605-14. PubMed ID: 3795940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The transformed glucocorticoid receptor has a lower steroid-binding affinity than the nontransformed receptor.
    Nemoto T; Ohara-Nemoto Y; Denis M; Gustafsson JA
    Biochemistry; 1990 Feb; 29(7):1880-6. PubMed ID: 2184891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-lapachone, a specific competitive inhibitor of ligand binding to the glucocorticoid receptor.
    Schmidt TJ; Miller-Diener A; Litwack G
    J Biol Chem; 1984 Aug; 259(15):9536-43. PubMed ID: 6746659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of 1,10-phenanthroline on the binding of activated rat hepatic glucocorticoid-receptor complexes to deoxyribonucleic acid-cellulose.
    Schmidt TJ; Sekula BC; Litwack G
    Endocrinology; 1981 Sep; 109(3):803-12. PubMed ID: 7262022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of in vivo activation of triamcinolone acetonide- and RU 38486-receptor complexes in the CEM-C7 and IM-9 human leukemic cell lines.
    Schmidt TJ
    Cancer Res; 1989 Aug; 49(16):4390-5. PubMed ID: 2743328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of the reversible thiol-reactive agents arsenite and methyl methanethiosulfonate on steroid binding by the glucocorticoid receptor.
    Stancato LF; Hutchison KA; Chakraborti PK; Simons SS; Pratt WB
    Biochemistry; 1993 Apr; 32(14):3729-36. PubMed ID: 8466913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinction between binding of [3H]triamcinolone acetonide to a ligand binding domain on the glucocorticoid receptor complex in cytosol fractions of brain and liver from the rat with intact adrenals.
    Yoneda Y; Han D; Ogita K; Watanabe A
    Brain Res; 1995 Jul; 685(1-2):105-16. PubMed ID: 7583234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence that pH induced activation of the rat hepatic glucocorticoid-receptor complex is irreversible.
    Bodine PV; Schmidt TJ; Litwack G
    J Steroid Biochem; 1984 Mar; 20(3):683-9. PubMed ID: 6708546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triamcinolone acetonide 21-oic acid methyl ester: a potent local antiinflammatory steroid without detectable systemic effects.
    Gorsline J; Bradlow HL; Sherman MR
    Endocrinology; 1985 Jan; 116(1):263-73. PubMed ID: 3855256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of a membrane-associated steroid binding site in rat liver.
    Wright MC; Paine AJ
    J Recept Signal Transduct Res; 1995; 15(1-4):543-56. PubMed ID: 8903963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of [3H]triamcinolone acetonide to glucocorticoid receptors in brain cytosol fractions of rats with intact adrenals.
    Han D; Ogita K; Kashiwai K; Narita S; Yoneda Y
    Neurochem Int; 1994 Apr; 24(4):339-48. PubMed ID: 8061598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stability and transformation of the glucocorticoid receptor under acidic conditions.
    Nemoto T; Ohara-Nemoto Y; Ota M
    J Biochem; 1988 Jun; 103(6):920-7. PubMed ID: 3170521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A profile of the intestinal mucosal corticosteroid receptors in the domestic duck.
    DiBattista JA; Mehdi AZ; Sandor T
    Gen Comp Endocrinol; 1985 Jul; 59(1):31-49. PubMed ID: 4018554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.